From FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies:

FDA headquarters in Washington DC.
FDA headquarters in Washington DC.

Image: iStock/JHVEPhoto
https://www.istockphoto.com/portfolio/jhvephoto?assettype=image&mediatype=photography&sort=best